Alharbi, O.; Alsaedi, W.H.; Alsehli, M.; Althagafi, S.H.; Alharbi, H.Y.; Asiri, Y.M.; Ramu, R.; Al-Ghorbani, M.
Novel Quinoline- and Naphthalene-Incorporated Hydrazineylidene–Propenamide Analogues as Antidiabetic Agents: Design, Synthesis, and Computational Studies. Pharmaceuticals 2024, 17, 1692.
https://doi.org/10.3390/ph17121692
AMA Style
Alharbi O, Alsaedi WH, Alsehli M, Althagafi SH, Alharbi HY, Asiri YM, Ramu R, Al-Ghorbani M.
Novel Quinoline- and Naphthalene-Incorporated Hydrazineylidene–Propenamide Analogues as Antidiabetic Agents: Design, Synthesis, and Computational Studies. Pharmaceuticals. 2024; 17(12):1692.
https://doi.org/10.3390/ph17121692
Chicago/Turabian Style
Alharbi, Osama, Wael H. Alsaedi, Mosa Alsehli, Saif H. Althagafi, Hussam Y. Alharbi, Yazeed M. Asiri, Ramith Ramu, and Mohammed Al-Ghorbani.
2024. "Novel Quinoline- and Naphthalene-Incorporated Hydrazineylidene–Propenamide Analogues as Antidiabetic Agents: Design, Synthesis, and Computational Studies" Pharmaceuticals 17, no. 12: 1692.
https://doi.org/10.3390/ph17121692
APA Style
Alharbi, O., Alsaedi, W. H., Alsehli, M., Althagafi, S. H., Alharbi, H. Y., Asiri, Y. M., Ramu, R., & Al-Ghorbani, M.
(2024). Novel Quinoline- and Naphthalene-Incorporated Hydrazineylidene–Propenamide Analogues as Antidiabetic Agents: Design, Synthesis, and Computational Studies. Pharmaceuticals, 17(12), 1692.
https://doi.org/10.3390/ph17121692
